Group of international scientist review options of surveillance-flanked HPAI vaccination
The highly pathogenic avian influenza virus (HPAIV) of the subtype H5 has progressed from sporadic seasonal occurrences to a continuous and nearly global panzootic in wild birds. This raises HPAIV incursion pressure into poultry holdings, as well as the risks of secondary spread and human exposure at the poultry-human interface. A group of international scientists outlines how vaccination with zero-tolerance for infection can be achieved by usefully supplementing multiple layers of appropriate surveillance.
The highly pathogenic avian influenza virus (HPAIV) of the subtype H5 has progressed from sporadic seasonal occurrences to a continuous and nearly global panzootic in wild birds. This raises HPAIV incursion pressure into poultry holdings, as well as the risks of secondary spread and human exposure at the poultry-human interface. A group of international scientists outlines how vaccination with zero-tolerance for infection can be achieved by usefully supplementing multiple layers of appropriate surveillance.
